home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
DP Tool Club 17
/
CD_ASCQ_17_101194.iso
/
vrac
/
med9408d.zip
/
M9480656.TXT
< prev
next >
Wrap
Text File
|
1994-08-27
|
1KB
|
27 lines
Document 0656
DOCN M9480656
TI Equal inhibition of the replication of human immunodeficiency virus in
human T-cell culture by ddA bis(SATE)phosphotriester and
3'-azido-2',3'-dideoxythymidine.
DT 9410
AU Perigaud C; Aubertin AM; Benzaria S; Pelicano H; Girardet JL; Maury G;
Gosselin G; Kirn A; Imbach JL; Laboratoire de Chimie Bio-Organique,
U.R.A. 488 du C.N.R.S.,; Universite de Montpellier II, France.
SO Biochem Pharmacol. 1994 Jul 5;48(1):11-14. Unique Identifier : AIDSLINE
MED/94318075
AB It is shown that ddA bis(SATE)phosphotriester is one of the most potent
anti-HIV agents in cell culture. Compared with the parent nucleoside,
ddA, an increase of 3 orders of magnitude was observed in the EC50,
which makes this compound as active as AZT. This can be tentatively
explained if one considers that direct ddAMP intracellular delivery
shunts the well established ddA/ddI metabolism pathway.
DE Antiviral Agents/*PHARMACOLOGY Cell Line Dideoxyadenosine/ANALOGS &
DERIVATIVES/*PHARMACOLOGY Drug Screening Human HIV/*DRUG
EFFECTS/PHYSIOLOGY Support, Non-U.S. Gov't T-Lymphocytes/*MICROBIOLOGY
Virus Replication/*DRUG EFFECTS Zidovudine/*PHARMACOLOGY JOURNAL
ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).